ライフサイエンスコーパス: intrauterine growth restriction

1 and abnormal placentation (preeclampsia and intrauterine growth restriction).

2 rths include pre-eclampsia or eclampsia, and intrauterine growth restriction.

3 iated with preeclampsia and fetal indication/intrauterine growth restriction.

4 reduce birth weight and increase the risk of intrauterine growth restriction.

5 lampsia, premature rupture of membranes, and intrauterine growth restriction.

6 tarting on gestational day 14.5 that induced intrauterine growth restriction.

7 -term), perinatal deaths, preterm birth, and intrauterine growth restriction.

8 sgenic mice showed fasting hyperglycemia and intrauterine growth restriction.

9 </=3-fold increased risk of preeclampsia and intrauterine growth restriction.

10 fetuses with long-term, chronic hypoxia and intrauterine growth restriction.

11 o an increased incidence of preeclampsia and intrauterine growth restriction.

12 y new onset hypertension and organ damage or intrauterine growth restriction.

13 s in scenarios such as premature delivery or intrauterine growth restriction.

14 ding microcephaly, spontaneous abortion, and intrauterine growth restriction.

15 ancy complications, such as preeclampsia and intrauterine growth restriction.

16 with structural malformations and linked to intrauterine growth restriction.

17 xy for the pathological process of interest, intrauterine growth restriction.

18 or gestational age and those with pathologic intrauterine growth restriction.

19 actor and placental growth factor levels and intrauterine growth restriction.

20 rent spontaneous abortion, preeclampsia, and intrauterine growth restriction.

21 gical deficits, hearing and vision loss, and intrauterine growth restriction.

22 ntal," which was preceded by preeclampsia or intrauterine growth restriction.

23 d nutritional status who were at low risk of intrauterine growth restriction.

24 e nutritional status who were at low risk of intrauterine growth restriction.

25 1.7%]); fetal distress (131 infants [9.5%]); intrauterine growth restriction (110 infants [8.0%]); se

26 ical incompetence (5%), and fetal indication/intrauterine growth restriction (3%).

27 ry tract (8/36 [22%] vs 2/71 [3%]; p=0.002), intrauterine growth restriction (34/37 [92%] vs 34/70 [4

28 , born after a preterm birth or secondary to intrauterine growth restriction, account for much of the

29 on may cause pregnancy complications such as intrauterine growth restriction and birth defects.

30 High-altitude hypoxia causes intrauterine growth restriction and cardiovascular progr

31 n and cardiovascular disease may result from intrauterine growth restriction and low birth weight ind

32 often leads to abortion, premature delivery, intrauterine growth restriction and low birth weight.

33 ads to devastating fetal outcomes, including intrauterine growth restriction and microcephaly.

34 tion and placental development, resulting in intrauterine growth restriction and perinatal lethality.

35 ctor to poor placental perfusion, leading to intrauterine growth restriction and preeclampsia, is the

36 associated with pregnancy disorders such as intrauterine growth restriction and preeclampsia, which

37 rther distinguish placental dysfunction from intrauterine growth restriction and reveal a role for th

38 ic membranes of placentas from newborns with intrauterine growth restriction and underlying congenita

39 may also have a role in the investigation of intrauterine growth restriction and unexplained stillbir

40 centation (cases who had preeclampsia and/or intrauterine growth restriction) and 2 cases that could

41 gestational diabetes, preterm delivery, and intrauterine growth restriction), and absence of breastf

42 as Turner's syndrome, Prader-Willi syndrome, intrauterine growth restriction, and chronic renal failu

43 Preterm birth, intrauterine growth restriction, and delivery-related hy

44 ization defects can cause poor placentation, intrauterine growth restriction, and early parturition l

45 ternal morbidity, stillbirth, preterm birth, intrauterine growth restriction, and fetal congenital an

46 ing miscarriage, fetal death, preterm birth, intrauterine growth restriction, and fetal microcephaly,

47 n gestational diseases such as preeclampsia, intrauterine growth restriction, and gestational diabete

48 as in preeclampsia with preterm delivery or intrauterine growth restriction, and in cancer.

49 ia, preterm birth, small for gestational age/intrauterine growth restriction, and perinatal mortality

50 logical processes that underlie miscarriage, intrauterine growth restriction, and pre-eclampsia, and

51 tational hypertension, gestational diabetes, intrauterine growth restriction, and preterm birth.

52 a, congenital transmission, pup viral loads, intrauterine growth restriction, and pup mortality compa

53 mice demonstrated increased amniotic fluid, intrauterine growth restriction, and reduced litter size

54 S) is characterized by recurrent fetal loss, intrauterine growth restriction, and vascular thrombosis

55 of membranes (aOR, 1.42; 95% CI, 1.08-1.86), intrauterine growth restriction (aOR, 1.17; 95% CI, 1.01

56 estational diabetes (GD), preterm birth, and intrauterine growth restriction, are associated with inc

57 ons, such as severe forms of preeclampsia or intrauterine growth restriction, are thought to arise fr

58 including pre-term birth, pre-eclampsia, and intrauterine growth restriction-are common interrelated

59 The cause of intrauterine growth restriction-associated hypertension

60 re collected in a Montreal, Canada, study of intrauterine growth restriction between May 1998 and Jun

61 G7-deficiency in developing embryos leads to intrauterine growth restriction, brought on by placental

62 Both models lead to intrauterine growth restriction but dissociate between a

63 ternal mortality, stillbirth, preterm birth, intrauterine growth restriction cause millions of deaths

64 utero in FASDEL mice and in another model of intrauterine growth restriction caused by ectopic expres

65 ontribute to strain-dependent differences in intrauterine growth restriction caused by reduced EGFR a

66 rediction and Prevention of Preeclampsia and Intrauterine Growth Restriction cohort, multiple serial

67 ogic abnormalities, developmental delay, and intrauterine growth restriction compared to full-term pa

68 c mutation of the mouse Mtrr gene results in intrauterine growth restriction, developmental delay, an

69 We generated a new model of intrauterine growth restriction due to fatty acid syntha

70 tal liver from a baboon (Papio sp.) model of intrauterine growth restriction due to MNR (70% global d

71 rm included placental growth retardation and intrauterine growth restriction, evidence of placental a

72 ognitive impairment, behavioral alterations, intrauterine growth restriction, feeding problems, and v

73 red placental and fetal development, causing intrauterine growth restriction, fetal morbidity, and mo

74 Fetuses affected by intrauterine growth restriction have an increased risk o

75 neutrophils at the fetal-maternal interface, intrauterine growth restriction, impaired placental deve

76 8 group A versus 0 group B (P < 0.007), and intrauterine growth restriction in 1 group A versus 1 gr

77 (wa2) homozygous embryos model EGFR-mediated intrauterine growth restriction in humans.

78 10(-/-) mice resulted in fetal resorption or intrauterine growth restriction in response to very low

79 lacental Igf2 could be a cause of idiopathic intrauterine growth restriction in the human.

80 ging mosquito-borne virus recently linked to intrauterine growth restriction including abnormal fetal

81 trate that ZIKV(BR) infects fetuses, causing intrauterine growth restriction, including signs of micr

82 1998-1999, the authors investigated whether intrauterine growth restriction (indexed by birth weight

83 ummary, there was a weak association between intrauterine growth restriction, indexed by birth length

84 Early signs of the disease included mild intrauterine growth restriction, infantile hypotonia, an

85 ncy complications, such as preterm delivery, intrauterine growth restriction, infertility, and miscar

86 Intrauterine growth restriction is a leading cause of pe

87 Intrauterine growth restriction is associated with a nep

88 Intrauterine growth restriction is associated with short

89 We find a sexually dimorphic response; intrauterine growth restriction is associated with subst

90 dence from preclinical studies suggests that intrauterine growth restriction is protective against la

91 Intrauterine growth restriction (IUGR) affects up to 10%

92 Placental insufficiency causes intrauterine growth restriction (IUGR) and disturbances

93 leading to pregnancy complications including intrauterine growth restriction (IUGR) and fetal resorpt

94 Prenatal and postnatal factors such as intrauterine growth restriction (IUGR) and high-fat (HF)

95 OINTS: Maternal nutrient restriction induces intrauterine growth restriction (IUGR) and leads to heig

96 Intrauterine growth restriction (IUGR) and low birth wei

97 sts in a relatively hypoxic environment, but intrauterine growth restriction (IUGR) and pre-eclampsia

98 Isolated intrauterine growth restriction (IUGR) and preeclampsia

99 ltitude (HA) residence increases the risk of intrauterine growth restriction (IUGR) and preeclampsia

100 weight (LBW) can result from prematurity or intrauterine growth restriction (IUGR) and result in sma

101 Race/ethnicity is associated with intrauterine growth restriction (IUGR) and small-for-ges

102 igh altitude (HA) increases the incidence of intrauterine growth restriction (IUGR) approximately thr

103 Pregnancy loss and intrauterine growth restriction (IUGR) are serious pregn

104 inguish small for gestational age (SGA) from intrauterine growth restriction (IUGR) as independent pr

105 Intrauterine growth restriction (IUGR) compromises fetal

106 Intrauterine growth restriction (IUGR) confers heritable

107 Intrauterine growth restriction (IUGR) decreases serum i

108 Intrauterine growth restriction (IUGR) decreases serum I

109 Intrauterine growth restriction (IUGR) enhances risk for

110 Placental insufficiency-induced intrauterine growth restriction (IUGR) fetuses have chro

111 Fetuses with intrauterine growth restriction (IUGR) have lower muscle

112 Fetuses with intrauterine growth restriction (IUGR) have reduced musc

113 Previous studies in fetuses with intrauterine growth restriction (IUGR) have shown that a

114 complications such as preeclampsia (PE) and intrauterine growth restriction (IUGR) in 20% of patient

115 KEY POINTS: Intrauterine growth restriction (IUGR) increases offspri

116 Intrauterine growth restriction (IUGR) increases suscept

117 Intrauterine growth restriction (IUGR) increases the ris

118 Intrauterine growth restriction (IUGR) is a common compl

119 Intrauterine growth restriction (IUGR) is a common compl

120 Intrauterine growth restriction (IUGR) is a failure to a

121 Intrauterine growth restriction (IUGR) is a leading caus

122 Intrauterine growth restriction (IUGR) is a pathology of

123 al ad libitum caloric intake superimposed on intrauterine growth restriction (IUGR) is associated wit

124 Intrauterine growth restriction (IUGR) is associated wit

125 Intrauterine growth restriction (IUGR) is associated wit

126 Intrauterine growth restriction (IUGR) is associated wit

127 Intrauterine growth restriction (IUGR) is associated wit

128 Intrauterine growth restriction (IUGR) is associated wit

129 Intrauterine growth restriction (IUGR) leads to developm

130 Intrauterine growth restriction (IUGR) leads to offsprin

131 Intrauterine growth restriction (IUGR) occurs both in hu

132 Placental insufficiency and intrauterine growth restriction (IUGR) of the fetus affe

133 We hypothesized that intrauterine growth restriction (IUGR) offspring hearts

134 ry measure, we also evaluated the effects of intrauterine growth restriction (IUGR) on carotenoid sta

135 Our objective was to determine the impact of intrauterine growth restriction (IUGR) on pancreatic vas

136 duced skeletal muscle mass in the fetus with intrauterine growth restriction (IUGR) persists into adu

137 Intrauterine growth restriction (IUGR) reduces skeletal

138 Environmental causes of intrauterine growth restriction (IUGR) remain poorly cha

139 Intrauterine growth restriction (IUGR) still accounts fo

140 KEY POINTS: Rodent models of intrauterine growth restriction (IUGR) successfully iden

141 Rodent models of intrauterine growth restriction (IUGR) successfully iden

142 KEY POINTS: Adults who were affected by intrauterine growth restriction (IUGR) suffer from reduc

143 eroplacental insufficiency with asymmetrical intrauterine growth restriction (IUGR) upon fetal (22d)

144 The risk of intrauterine growth restriction (IUGR) was increased in

145 med MIRAGE syndrome that is characterized by intrauterine growth restriction (IUGR) with gonadal, adr

146 ss that manifests maternal hyperinsulinemia, intrauterine growth restriction (IUGR), and adverse offs

147 ce also leads to decreased beta cell growth, intrauterine growth restriction (IUGR), and impaired pla

148 l magnetic resonance imaging (MRI) to detect intrauterine growth restriction (IUGR), as well as the s

149 in patients with recurrent miscarriages and intrauterine growth restriction (IUGR), but the mediator

150 In cases of intrauterine growth restriction (IUGR), fetal weight-spe

151 TRACT: Maternal nutrient restriction induces intrauterine growth restriction (IUGR), increasing later

152 BSTRACT: Maternal nutrient reduction induces intrauterine growth restriction (IUGR), increasing risks

153 Metabolic syndrome (MetS), following intrauterine growth restriction (IUGR), is epigeneticall

154 this cell-fusion process are associated with Intrauterine Growth Restriction (IUGR), Preeclampsia (PE

155 aracterize the potential long-term impact of intrauterine growth restriction (IUGR), we assessed the

156 erm birth (PTB), low birth weight (LBW), and intrauterine growth restriction (IUGR).

157 , is associated with fetuses who suffer from intrauterine growth restriction (IUGR).

158 ary metabolites in umbilical cord blood with intrauterine growth restriction (IUGR).

159 s increased in vivo in preeclampsia (PE) and intrauterine growth restriction (IUGR).

160 ntal perfusion, to enable early detection of intrauterine growth restriction (IUGR).

161 embolization in sheep is a reliable model of intrauterine growth restriction (IUGR).

162 megranate juice exposure in pregnancies with intrauterine growth restriction (IUGR).

163 down-regulated in placentas of infants with intrauterine growth restriction (IUGR).

164 t is one of the main etiological factors for intrauterine growth restriction (IUGR).

165 as not been shown to prevent preeclampsia or intrauterine growth restriction (IUGR).

166 ectd1 results in mid-gestation lethality and intrauterine growth restriction (IUGR).

167 Congenital infection is also associated with intrauterine growth restriction (IUGR).

168 d atherosclerosis using two mouse models for intrauterine growth restriction (IUGR): maternal protein

169 fetal outcomes compared with controls, with intrauterine growth restriction leading to higher rates

170 condition is characterized by short stature, intrauterine growth restriction, lipoatrophy and a facia

171 n papillomavirus may also be associated with intrauterine growth restriction, low birth weight, and f

172 l outcomes for the fetus and newborn include intrauterine growth restriction, low birth weight, and s

173 IMAGe syndrome (intrauterine growth restriction, metaphyseal dysplasia,

174 a, maternal hypertension in conjunction with intrauterine growth restriction mimicked aspects of pree

175 gnancy complications including preeclampsia, intrauterine growth restriction, miscarriage, and preter

176 Unexplained intrauterine growth restriction of the fetus (IUGR) resu

177 (44%) had normal outcome, 14 (33%) developed intrauterine growth restriction of the fetus (IUGR), and

178 dies have evaluated the effect of malaria on intrauterine growth restriction on the basis of the feta

179 asion shortly after implantation, along with intrauterine growth restriction or embryonic death.

180 with various confounding factors, including intrauterine growth restriction or factors related to th

181 m either singleton gestations complicated by intrauterine growth restriction or from dizygotic twin g

182 ome (3 women had used LMWH); and 11 cases of intrauterine growth restriction or placental insufficien

183 with normal outcomes (N = 29) and those with intrauterine growth restriction or preeclampsia (N = 12)

184 horioamnionitis (OR, 4.1; 95% CI, 1.6-10.1), intrauterine growth restriction (OR, 4.0; 95% CI, 1.3-12

185 amino acid transport are decreased in human intrauterine growth restriction our data are consistent

186 major concern in pregnancy than can lead to intrauterine growth restriction, placental abruption and

187 -0.95]; 13 RCTs [n = 13 619]; I2 = 49%), and intrauterine growth restriction (pooled RR, 0.82 [95% CI

188 DNA in amniotic fluid and/or newborn saliva, intrauterine growth restriction, preterm deliveries, and

189 ment, and pregnancy complications, including intrauterine growth restriction, preterm delivery, and s

190 sex, gestation, bronchopulmonary dysplasia, intrauterine growth restriction, pretreatment corticoste

191 results of these meta-analyses suggest that intrauterine growth restriction protects against allergi

192 priate management of pregnancies at risk for intrauterine growth restriction relies on accurate ident

193 R, 4.46 [95% CI, 1.02-19.52]) and lapatinib (intrauterine growth restriction: ROR, 7.68 [95% CI, 3.01

194 , 0.76 [95% CI, 0.62 to 0.95]), 1% to 5% for intrauterine growth restriction (RR, 0.80 [CI, 0.65 to 0

195 a single First Nations population and causes intrauterine growth restriction, severe microcephaly, cr

196 feeding difficulties; growth issues, such as intrauterine growth restriction, short stature, and micr

197 us (ZIKV) infection in pregnant women causes intrauterine growth restriction, spontaneous abortion, a

198 nancy complications, including preeclampsia, intrauterine growth restriction, spontaneous abortion, p

199 rediction and Prevention of Preeclampsia and Intrauterine Growth Restriction study reported depressiv

200 rediction and Prevention of Preeclampsia and Intrauterine Growth Restriction) study were followed up

201 e of the p.[P33S(;)P168S] variant in ROP and intrauterine growth restriction suggests that it also ma

202 ommon pregnancy complication associated with intrauterine growth restriction that may influence respi

203 We used a sheep model of intrauterine growth restriction to study the capacity of

204 ad evidence of severe CMV disease, including intrauterine growth restriction, ventriculomegaly, micro

205 mice results in high viral titers and severe intrauterine growth restriction, which are exacerbated b

206 rlying placental pathologies associated with intrauterine growth restriction, which is a significant